The Polypill in the prevention of cardiovascular disease

Prev Med. 2011 Jan;52(1):16-7. doi: 10.1016/j.ypmed.2010.11.015. Epub 2010 Dec 2.

Authors

David S Wald¹, Nicholas J Wald

Affiliation

¹ Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom. d.s.wald@qmul.ac.uk

PMID: 21130112
DOI: 10.1016/j.ypmed.2010.11.015

No abstract available

Publication types

Comment

MeSH terms

Antihypertensive Agents / administration & dosage*
Aspirin / administration & dosage*
Cardiovascular Diseases / prevention & control*
Drug Combinations
Evidence-Based Medicine
Folic Acid / administration & dosage
Hematinics / administration & dosage
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Platelet Aggregation Inhibitors / administration & dosage*
Primary Prevention / methods
United States

Substances

Antihypertensive Agents
Drug Combinations
Hematinics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Platelet Aggregation Inhibitors
Folic Acid
Aspirin